Joyn Bio
Signal active
Organization
Contact Information
Overview
Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.
About
Industries
Biotechnology, Health Care, Agriculture, Environmental Consulting
Founded
2017
Employees
51-100
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Joyn Bio headquartered in United States, North America, operates in the Biotechnology, Health Care, Agriculture, Environmental Consulting sector. The company focuses on Biotechnology and has secured $6.4B in funding across 32 round(s). With a team of 51-100 employees, Joyn Bio is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Joyn Bio, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
2
Investors
3
Lead Investors
0
Total Funding Amount
$200.0M
Details
2
Joyn Bio has raised a total of $200.0M in funding over 2 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 100.0M | ||
| 2017 | Early Stage Venture | 100.0M |
Investors
Joyn Bio is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jason Kelly | - | FUNDING ROUND - Jason Kelly | 100.0M |
| Ginkgo Bioworks | - | FUNDING ROUND - Ginkgo Bioworks | 100.0M |
| Joyn Bio | - | FUNDING ROUND - Joyn Bio | 100.0M |
| Viking Global Investors | - | FUNDING ROUND - Viking Global Investors | 100.0M |
Recent Activity
There is no recent news or activity for this profile.